Back to search results
NCT05948618

Improving PRO for Patients With Cancer Using ECAs and Data Visualization

Enrolling by Invitation
NAAges 18+InterventionalSupportive care
Tufts Medical Center
~100 participants
Updated 2026-03-04 on ClinicalTrials.gov
What's tested:Embodied Conversational AgentREDCap Survey

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
The degree of missing data will be investigated to gauge the extent to which patients are actively engaging with the ECA-PRO system.
Measured over 6 weeks

Conditions

Cancer

Explore related trials

Malignant Digestive System NeoplasmMalignant Head and Neck Neoplasm

Where it's being run

1 sites across 1 states
Massachusetts1

Study leadership

  • Michael Paasche-Orlow, MD, MPH · PRINCIPAL_INVESTIGATOR · Tufts Medical Center

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

At least 18 years of age or older
Able to read and speak english
Can independently consent
Must have adequate corrected vision to use the ECA system (based on a 1 minute ECA functional screener)
Must have adequate hearing to use the ECA system.
Has a diagnosis of gastrointestinal cancer or head and neck cancer for which they are currently receiving chemotherapy and/or radiation treatment.
Provider subjects must be practicing oncologists at BMC.

Exclusion

If the subject is incarcerated
If the subject plans to leave the Boston area in the next 6 weeks
Is not able to use the ECA screener

What this trial measures

  • The degree of missing data will be investigated to gauge the extent to which patients are actively engaging with the ECA-PRO system.6 weeks

    Assessing the completeness of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) survey questions, taking into account the number of items that have been satisfactorily completed. By examining prevalence of missing data, the investigators aim to infer the level of patient utilization of the ECA-PRO system.